Kyron.bio

Kyron.bio

Pre-clinical
Paris, FranceFounded 2021kyron.bio

kyron.bio unlocks superior protein therapeutics by harnessing the power of glycan modifications.

Market Cap
Private
Pipeline
Patents
Publications

Private Company

Total funding raised: $15M

About

kyron.bio unlocks superior protein therapeutics by harnessing the power of glycan modifications.

AntibodiesBiologics

Funding History

2
Total raised:$15M
Series A$12MMay 15, 2022
Seed$3MSep 15, 2020